Cargando…

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up

BACKGROUND: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is a treatment option for patients with type 1 diabetes mellitus (T1DM). Aim of the present study was to describe the long-term course of glycaemic control, complications, health related quality of life (HRQOL)...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Peter R, Logtenberg, Susan JJ, Groenier, Klaas H, Gans, Rijk OB, Kleefstra, Nanne, Bilo, Henk JG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029992/ https://www.ncbi.nlm.nih.gov/pubmed/24708696 http://dx.doi.org/10.1186/1472-6823-14-30

Ejemplares similares

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes
por: van Dijk, Peter R., et al.
Publicado: (2020)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

Route of Insulin Does Not Influence 25-Hydroxyvitamin D Concentrations in Type 1 Diabetes: A Brief Report
por: van Dijk, Peter R, et al.
Publicado: (2019)

Effects of intraperitoneal insulin versus subcutaneous insulin administration on sex hormone-binding globulin concentrations in patients with type 1 diabetes mellitus
por: Boering, M, et al.
Publicado: (2016)

Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
por: Landman, Gijs WD, et al.
Publicado: (2012)

Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet
por: van der Horst, Iwan CC, et al.
Publicado: (2003)

Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus
por: van Dijk, Peter R., et al.
Publicado: (2019)

Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
por: Hendriks, Steven H, et al.
Publicado: (2014)

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
por: Roelofsen, Yvonne, et al.
Publicado: (2014)

The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2009)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
por: Drion, Iefke, et al.
Publicado: (2012)

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1)
por: Nijenhuis-Rosien, Leonie, et al.
Publicado: (2015)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials
por: Landman, Gijs W. D., et al.
Publicado: (2014)

Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes
por: van Dijk, P R, et al.
Publicado: (2014)

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial
por: Hortensius, Johanna, et al.
Publicado: (2018)

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
por: Drion, Iefke, et al.
Publicado: (2012)

Increased Insulin Requirements During Exercise at Very High Altitude in Type 1 Diabetes
por: de Mol, Pieter, et al.
Publicado: (2011)

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients
por: Gerrits, Esther G., et al.
Publicado: (2012)

Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3
por: van Dijk, Peter R, et al.
Publicado: (2015)

A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19)
por: van Hateren, Kornelis J J, et al.
Publicado: (2012)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
por: Riphagen, Ineke J., et al.
Publicado: (2013)

Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2012)

Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study
por: Hortensius, Johanna, et al.
Publicado: (2012)

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)
por: Hendriks, Steven H., et al.
Publicado: (2018)

Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45)
por: Hendriks, Steven H., et al.
Publicado: (2015)

Validation of the howRu and howRwe questionnaires at the individual patient level
por: Hendriks, Steven H., et al.
Publicado: (2015)

Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?
por: Hendriks, Steven H., et al.
Publicado: (2016)

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50)
por: Hendriks, Steven H, et al.
Publicado: (2017)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1ujdgvkdmt1t0rde4u1veic1f3